Stem Cell Patents: An Analysis
|
|
|
- Kristin Hubbard
- 6 years ago
- Views:
Transcription
1 Stem Cell Patents: An Analysis Antoinette F. Konski, Esq. Partner, Foley & Lardner, LLP Doris Spielthenner Partner and Vice President, FAS.research February 2008 Attorney Advertising Prior results do not guarantee a similar outcome Models used are not Data Analysis Delphion Database The INPADOC collection provides over 30 million patent family documents from 71 patent offices worldwide, and 45 million legal status actions from 42 worldwide patent offices. INPADOC is the most comprehensive database in which to perform patent family searches on a worldwide basis, and is estimated to cover 95% of all patents published since Attorney Advertising Prior results do not guarantee a similar outcome Models used are not
2 Analysis Methodology Network Analysis Identifies relationships between literature, authors, assignees and patents Patent Importance or Dominance One measure is the number of later filed patents/applications that reference the patent or application, see Bergman & Graff (2007) The global stem cell patent landscape: implications for efficient technology transfer and commercial development, Nature Biotechnology, Vol. 25(4):419 Search Query Search Query: stem cells in the claims Approximately 8,000 patents identified 288 patents identified as important based on crossreferencing Attorney Advertising Prior results do not guarantee a similar outcome Models used are not
3 Clusters Issue/publication dates 1980s to to to 2008 Subject Matter Adult or somatic stem cells Embryonic stem cells: Human and non-human Stem Cell Citation Trees Main component of stem cell citation trees Strong lines between two patents indicates the patents are highly referenced by each other and others Attorney Advertising Prior results do not guarantee a similar outcome Models used are not
4 Citation Tree 70ies 90ies 2000 till Citation Tree - Dates 70ies 90ies 2000 till Attorney Advertising Prior results do not guarantee a similar outcome Models used are not
5 Research Clusters A1 Manipulating stem cells/protein markers B1 embryonic C1 Non-human stem cell research Culturing hematopoietic stem cells A2 B2 Culturing neural stem cells 70ies 90ies 2000 till Cluster A1 Manipulating stem cells/protein markers Attorney Advertising Prior results do not guarantee a similar outcome Models used are not
6 Cluster A2 Culturing hematopoietic stem cells Cluster B1 B1 Attorney Advertising Prior results do not guarantee a similar outcome Models used are not
7 Cluster B2 Cluster C1 C1 Non-human stem cell research Attorney Advertising Prior results do not guarantee a similar outcome Models used are not
8 Center Cluster Top 25 Patents - Bridging patents - Patents linking the most various fields of stem cell research Attorney Advertising Prior results do not guarantee a similar outcome Models used are not
9 No. 1 No. 2 Attorney Advertising Prior results do not guarantee a similar outcome Models used are not
10 Conclusions No significant shift from US patents to non-us patents after 2005 May be too early to see trends From , adult stem cell research remained strong based on early 80 s/90 s patent filings Few embryonic stem cell patents prior to 2005 Embryonic stem cell patents appear to bridge non-human embryonic stem cell and adult stem cell patents Contact Information Antoinette F. Konski Foley & Lardner, LLP akonski@foley.com Doris Spielthenner FAS.research doris.spielthenner@fas-research.com Attorney Advertising Prior results do not guarantee a similar outcome Models used are not
2009: GROWTH PROSPECTS ABOUND IN NEW INVENTIONS AND LICENSING
2009: GROWTH PROSPECTS ABOUND IN NEW INVENTIONS AND LICENSING Solar, Wind, and Hybrid Vehicle Lead the Way Among 589 patents issued in 2008 across the nine categories of the Cleantech landscape studied,
Cleantech Energy Patent Landscape. Executive Summary
Cleantech Energy Patent Landscape Executive Summary 2010 A GUIDE TO NAVIGATING CLEANTECH Cleantech innovations continued to thrive in 2009 despite the economic downturn, and sources indicate that the industry
New Paradigms for Advancing Personalized Medicine
1 2 New Paradigms for Advancing Personalized Medicine 1 Panelists Moderated by: Antoinette Konski, Partner, Foley & Lardner LLP Speakers: Anita Chawla, Ph.D., Vice President, Analysis Group Ken Goldman,
Cases of Academic Misconduct. Core Components
Cases of Academic Misconduct May 2015 Examination Session Core Components Extended Essay / Biology Infringement: Plagiarism Pages 1-6 show no evidence of plagiarism. Comments A significant portion of the
Collaborating and Making Money from your Data and IP
Collaborating and Making Money from your Data and IP - the Good, the Bad, and the Ugly November 7, 2017 Panelists and Speakers Toni Y. Hickey Dr. Elvir Causevic Henry Unger Beni Surpin Deputy General Counsel
Patenting Personalized Medicine in the Wake of Mayo v. Prometheus. Antoinette F. Konski August 24 th, 2012
1 Patenting Personalized Medicine in the Wake of Mayo v. Prometheus Antoinette F. Konski August 24 th, 2012 2 Roadmap Supreme Court invalidates diagnostic method claims in Mayo v. Prometheus, 132 S. Ct.
Practical Challenges and Solutions to Implementing a Compliance Program in the Not-For-Profit Sector
Implementing a Compliance Program in the Not- Society of Corporate Compliance and Ethics Annual Institute Las Vegas, Nevada September 15, 2009 Presenters: Marcella Henry Compliance Officer, Sunrise Community,
Getting Started with PatSnap Workspaces
Getting Started with PatSnap Workspaces Table of Contents The Importance of Collaboration 3 The Role of Workspaces 3 Creating a Workspace 5 Managing Your Workspace 6 Custom Fields 8 Automatic Updates 9
California Construction General Permit Web Conference
California Construction General Permit Web Conference Session V Understanding the electronic submittal process using the Storm Water Multiple Application and Report Tracking System (SMARTS)! Wednesday
Patent Citation Spectroscopy (PCS): Algorithmic retrieval of landmark patents
Patent Citation Spectroscopy (PCS): Algorithmic retrieval of landmark patents Jordan A. Comins 1,*,, Stephanie A. Carmack 2, and Loet Leydesdorff 3 Abstract One essential component in the construction
Freedom to Operate. Sample Report 2/25/2016. Ruchica Kumar NOVOCUS LEGAL LLP
2/25/2016 Freedom to Operate Sample Report Ruchica Kumar NOVOCUS LEGAL LLP CONTENTS Introduction... 2 Objective... 2 Methodology... 2 Search Assumptions... 3 Key Features... 3 Key Strings... 4 Search Results
Medicare Compliance & Operations Summit The Role of Internal Audit in Medicare Programs
Medicare Compliance & Operations Summit 2007 Structuring Seamless Internal Auditing Procedures Robert E. Slavkin Senior Counsel Foley & Lardner LLP Richard J. Merino Manager Huron Consulting Group Attorney
Governance for Non-Profits
2 Governance for Non-Profits March 24, 2010 Attorney Advertising Prior results do not guarantee a similar outcome Models used are not clients but may be representative of clients 321 N. Clark Street, Suite
Supplemental Information. 1. Patent Search Methodology
Supplemental Information 1. Patent Search Methodology Thomson Innovation and Thomson Data Analyzer software were utilized to perform patent data mining. The search includes both granted patents and published
A multidimensional approach to visualising and analysing patent portfolios
A multidimensional approach to visualising and analysing patent portfolios Edwin Horlings Global TechMining Conference, Leiden, 2 September 2014 2 A multidimensional approach to visualising and analysing
IN THE UNITED STATES PATENT AND TRADEMARK OFFICE
IN THE UNITED STATES PATENT AND TRADEMARK OFFICE In the matter of: Reexamination Control. No. 95/000,154 Art Unit: 3991 U.S. Patent No. 7,029,913 Issued: April 18, 2006 Examiner: Gary L. Kunz Inventor:
Yearbook. Building IP value in the 21st century. Making better, faster portfolio management decisions with big data insight
Making better, faster portfolio management decisions with big data insight Practice Insight GmbH Doris Spielthenner Yearbook 2018 Building IP value in the 21st century Grow your business by gaining insight
BIOTECHNOLOGY. Unit 8
BIOTECHNOLOGY Unit 8 PART 1 BASIC/FUNDAMENTAL SCIENCE VS. APPLIED SCIENCE! Basic/Fundamental Science the development and establishment of information to aid our understanding of the world.! Applied Science
From Resilience To Growth:
From Resilience To Growth: Mapping a New Direction for Life Sciences & Medical Devices Attorney Advertising Prior results do not guarantee a similar outcome Models used are not Mapping the Way: Opportunities
Propositions on Genetic Engineering: Assignment 3/13 Integrated Science 4 Redwood High School Name: Per:
Propositions on Genetic Engineering: Assignment 3/13 Integrated Science 4 Redwood High School Name: Per: n Introduction Since the early 1950 s, advances in the field of genetics have reshaped the science
Private Company Corporate Governance Best Practices. November 7, 2017
Private Company Corporate Governance Best Practices November 7, 2017 Panelists Paul Broude Foley & Lardner LLP Cindy Burrell Diversity in Boardrooms Steven Gerenraich Foley & Lardner LLP Ahna Severts Wilton
Dance Dance Dance: Unveiling the Intricacy in Biosimilar Litigation
Dance Dance Dance: Unveiling the Intricacy in Biosimilar Litigation Peng Sun, Ph.D., J.D. Foley & Lardner LLP August 26, 2017 Attorney Advertising Prior results do not guarantee a similar outcome Models
Managing the Due Diligence Process: Keys for Success
Managing the Due Diligence Process: Keys for Success R. Brian McCaslin Foley & Lardner LLP Matt Bastardi Covidien Stages of Diligence Initial Analysis Market Assessment Product Assessment Customer Assessment
Intellectual property rights, agricultural innovation, and developing countries. Sara Boettiger UC Davis & UC Berkeley October 2008
Intellectual property rights, agricultural innovation, and developing countries Sara Boettiger UC Davis & UC Berkeley October 2008 www.pipra.org Supporting public sector agricultural innovation for poverty
Using Economic Development Incentives for Capital Investment, Site Expansion, Site Selection. November 7, 2017
Using Economic Development Incentives for Capital Investment, Site Expansion, Site Selection November 7, 2017 2 Panelists Bruce Keyes Foley & Lardner (moderator) Mike Eickhoff Grant Thornton Vineet Sahgal
Testimony of the Biotechnology Industry Organization (BIO) Before the Texas House of Representatives State Affairs Committee
Testimony of the Biotechnology Industry Organization (BIO) Before the Texas House of Representatives State Affairs Committee Regarding House Bill 1929 The Use of Human Cells and Tissue April 11, 2005 Thank
California Construction General Permit Web Conference
California Construction General Permit Web Conference Session IV: New Regulations of the Rain Event Action Plan (REAP) Wednesday, January 27, 2010 12:00 p.m. 1:30 p.m. For audio participation Dial: 1.866.238.0637;
Pearson Agriscience Explorations 4 th Edition, 2013
Pearson Agriscience Explorations 4 th Edition, 2013 Florida Department of Education Instructional Materials Correlation Exploration of Agriscience Course Code 8100210 CORRELATION FLORIDA DEPARTMENT OF
Rewards and Risks of Green Web Conference Series
Rewards and Risks of Green Web Conference Series Where Innovation is Meeting Investment May 11, 21 Attorney Advertising Prior results do not guarantee a similar outcome Models used are not clients but
Stony Brook University Human Stem Cell Research Policy (August 15, 2013 version)
Stony Brook University Human Stem Cell Research Policy (August 15, 2013 version) I. Purpose This policy is intended to ensure that all research involving the derivation or use of human pluripotent stem
Fundamental properties of Stem Cells
Stem cells Learning Goals: Define what a stem cell is and describe its general properties, using hematopoietic stem cells as an example. Describe to a non-scientist the current progress of human stem cell
Chapter 11: Applications of Biotechnology
Chapter 11: Applications of Biotechnology Lecture Outline Enger, E. D., Ross, F. C., & Bailey, D. B. (2012). Concepts in biology (14th ed.). New York: McGraw- Hill. 11-1 Why Biotechnology Works 11-2 Biotechnology
Dec 04, 2013
Stem Cells Junfeng Ji ( 纪俊峰 ), PhD Professor Research Center of Stem Cell and Developmental Biology School of Medicine Zhejiang University Email: jijunfeng@zju.edu.cn Dec 04, 2013 Totipotent Pluripotent
SEMINAR SERIES NEW SESSIONS. SECURITIES ERISA and fiduciary liability ANTITRUST ISSUES IN HEALTH CARE
SEMINAR SERIES 2018 2019 NEW SESSIONS SECURITIES ERISA and fiduciary liability ANTITRUST ISSUES IN HEALTH CARE M&A LITIGATION Share price; disclosure; and governance WHITE COLLAR and SEC LITIGATION INTELLECTUAL
Chapter 15 Gene Technologies and Human Applications
Chapter Outline Chapter 15 Gene Technologies and Human Applications Section 1: The Human Genome KEY IDEAS > Why is the Human Genome Project so important? > How do genomics and gene technologies affect
Sexual Harassment Prevention
Sexual Harassment Prevention Introduction Disclaimer: Any and all information contained herein shall not be construed as legal advice and, accordingly, you should consult with your own attorneys when developing
Beyond evidence and regulation: Medical tourism and the direct-to-consumer marketing of stem cell therapies
Beyond evidence and regulation: Medical tourism and the direct-to-consumer marketing of stem cell therapies Ubaka Ogbogu, LLB, BL, LLM Adjunct Associate Professor of Law Associate Director of Research
Genetically Engineered Organisms Perspective A
Genetically Engineered Organisms Perspective A General Information Genetically engineered (GE) plants and animals have the potential to be one of the greatest discoveries in the history of farming. Improvements
Ric Snead, Presenter Nancy Lee, Moderator
AurekaKNOW 3: R & D ANALYSIS UNDERSTANDING MARKETS Ric Snead, Presenter Nancy Lee, Moderator AGENDA Quick review of sessions 1 and 2 Common Data Types Analysis Types Efficiency / Visualization Tools Graphics
Name of Journal: World Journal of Experimental Medicine ESPS Manuscript NO: Manuscript Type: ORIGINAL ARTICLE
Name of Journal: World Journal of Experimental Medicine ESPS Manuscript NO: 25814 Manuscript Type: ORIGINAL ARTICLE Comments Response Reviewer 1 Authors studied differentiation of hescs cell line into
Best Practices for On- and Off- Boarding Lateral Attorneys
Best Practices for On- and Off- Boarding Lateral Attorneys Beth Chiaiese, CRM Director, Professional Responsibility & Compliance Attorney Advertising Prior results do not guarantee a similar outcome Models
ICIC 2010, Vienna. Diane Webb, President 27 October 2010
Techniques for Evaluating Conflicting Information in Multi-Database Patents and Drug Pipeline Reports ICIC 2010, Vienna Diane Webb, President 27 October 2010 The Problem When creating pipeline and patents
This Webcast Will Begin Shortly
This Webcast Will Begin Shortly If you have any technical problems with the Webcast or the streaming audio, please contact us via email at: webcast@acc.com Thank You! Personalized Medicine Promise and
Intellectual Property Solutions
Aon Risk Solutions Intellectual Property Solutions Redefining the Business of Intellectual Property With $19 trillion, or nearly 85% of the value of the S&P 500 represented by intangible assets, investment
Update on Current FDA Policies and Priorities
Update on Current FDA Policies and Priorities Vernessa Pollard MassMEDIC FDA Update December 12, 2017 Boston Brussels Chicago Dallas Düsseldorf Frankfurt Houston London Los Angeles Miami Milan Munich New
Global Gene Therapy Market Report -2026
Global Gene Therapy Market Report -2026 July 2018 Table of Contents 1 Executive Summary 2 Gene Therapy: Overview Viral Vectors for Gene Therapy Viral Vectors Non-Viral Vectors Types of Gene Therapy Somatic
Stem Cells & Neurological Disorders. Said Ismail Faculty of Medicine University of Jordan
Stem Cells & Neurological Disorders Said Ismail Faculty of Medicine University of Jordan Outline: - Introduction - Types & Potency of Stem Cells - Embryonic Stem Cells - Adult Stem Cells - ipscs -Tissue
Is Your Law Firm Simply A Vendor Or A Partner?
And Its Member Firms Present Is Your Law Firm Simply A Vendor Or A Partner? Visit us at ACE at booth 309 What is the difference between a Legal Vendor and a Legal Partner? A Vendor A Partner One who sells
Chapter 8 Healthcare Biotechnology
Chapter 8 Healthcare Biotechnology Outline: 8.1 Introduction 8.2 Biopharming 8.3 Models of Human Disease 8.4 Detecting and Diagnosing Human Disease 8.5 Monoclonal Antibodies 8.6 Gene Therapy 8.7 Tissue
Developing a "Cookbook" of Reports & Visualizations for Drug Target CI
BizInt Smart Charts 2014 1 Developing a "Cookbook" of Reports & Visualizations for Drug Target CI February 18, 2014 Pharma CI Europe, Barcelona Diane Webb, President, BizInt Solutions John Willmore, VP,
Oracle Stream Analytics
Oracle Stream Analytics Oracle Stream Analytics allows users to process and analyze large scale realtime information by using sophisticated correlation patterns, enrichment, and machine learning. It offers
California Construction General Permit Web Conference. Session III: Hydromodification Management
California Construction General Permit Web Conference Session III: Hydromodification Management Wednesday, November 18, 2009 12:00 p.m. 1:30 p.m. For audio participation Dial: 1.866.206.7204; Passcode
Fig. 5.1(a) and Fig. 5.1(b), on page 3 of the insert, show some changes that take place in the fermenter over the first 6 days.
1 A batch fermenter is used during the production of beer. Fig. 5.1(a) and Fig. 5.1(b), on page 3 of the insert, show some changes that take place in the fermenter over the first 6 days. (a) (i) Describe
Successful and Faster Drug Development through Data Mining Dirk Belmans, Ph.D. SAS Belgium
Successful and Faster Drug Development through Data Mining Dirk Belmans, Ph.D. SAS Belgium The Life-Cycle of a Successful Pharmaceutical Product Sales Costs Patent Filing R&D time to launch is decreasing
Stem Cells in Life and Disease: Immortality Inside You
Stem Cells in Life and Disease: Immortality Inside You Blair Benham-Pyle Tyler Burns Joe Ouadah Splash! Fall 2011 What do you think a stem cell is? (discuss with people around you) A stem cell is a cell
Reach active buyers of stem cell research supplies and services in laboratories worldwide
Reach active buyers of stem cell research supplies and services in laboratories worldwide Stem Cell Lab World Choose either a full-page or 1/2-page (column) or both. Every ad placed in SCLW is also published
Client Alert. FDA Offers New Guidance on Acceptance of Foreign Clinical Trials. Introduction. FDA Regulation of Foreign Clinical Trials 6
Number 1325 April 23, 2012 Client Alert Latham & Watkins Corporate Department FDA Offers New Guidance on Acceptance of Foreign Clinical Trials Introduction With this newly released guidance, the FDA seeks
NPTEL Biotechnology Tissue Engineering. Stem cells
Stem cells S. Swaminathan Director Centre for Nanotechnology & Advanced Biomaterials School of Chemical & Biotechnology SASTRA University Thanjavur 613 401 Tamil Nadu Joint Initiative of IITs and IISc
What Your Board Needs to Know About IT
What Your Board Needs to Know About IT 2 0 0 7 N A TIONAL DIRECTORS INSTITUTE 2007 Foley & Lardner LLP Attorney Advertising Prior results do not guarantee a similar outcome 321 N. Clark Street, Suite 2800,
UvA-DARE (Digital Academic Repository) The potency of human testicular stem cells Chikhovskaya, J.V. Link to publication
UvA-DARE (Digital Academic Repository) The potency of human testicular stem cells Chikhovskaya, J.V. Link to publication Citation for published version (APA): Chikhovskaya, J. V. (2013). The potency of
Cloning. 1. What is cloning: Natural and artificial 2. Cloning of what? 3. Embryonic development of multi-cellular organisms:
Cloning 1. What is cloning: Natural and artificial 2. Cloning of what? 3. Embryonic development of multi-cellular organisms: cell division, morphogenesis, differentiation 2. Plant cloning 3. Animal cloning
IN THE UNITED STATES PATENT AND TRADEMARK OFFICE BEFORE THE PATENT TRIAL AND APPEAL BOARD. BioGatekeeper, Inc. Petitioner
IN THE UNITED STATES PATENT AND TRADEMARK OFFICE BEFORE THE PATENT TRIAL AND APPEAL BOARD BioGatekeeper, Inc. Petitioner v. Kyoto University Patent Owner U.S. Patent No. 8,058,065 to Yamanaka et al. Issue
The Science of Stem Cell Therapy
The Science of Stem Cell Therapy AVM Biotechnology City Centre Building 1420 Fifth Avenue, Suite 2650 Seattle, WA 98101 206-906-9922 www.avmbiotech.com Copyright 2008 AVM Biotechnology, LLC speaker disclosure
All contents herein are the sole property of MEDIPOST Co., Ltd. Any reproduction or distribution of this document without the written consent of
All contents herein are the sole property of MEDIPOST Co., Ltd. Any reproduction or distribution of this document without the written consent of MEDIPOST Co., Ltd is prohibited. Copyright c 2004-2011 MEDIPOST.
Human embryo and stem cell patenting
Human embryo and stem cell patenting David Lancaster Biotechnology Directive (98/44/EC) Article 6 1. Inventions shall be considered unpatentable where their commercial exploitation would be contrary to
Mid-term review. Recitation5 03/31/2014. Stem Cell Biology and Function W4193 1
Mid-term review Recitation5 03/31/2014 Stem Cell Biology and Function W4193 1 What to expect in the midterm2 It will be all so far but mainly whatever was NOT covered by the previous mid-term- not a huge
ANNOUNCEMENTS. HW2 is due Thursday 2/4 by 12:00 pm. Office hours: Monday 12:50 1:20 (ECCH 134)
ANNOUNCEMENTS HW2 is due Thursday 2/4 by 12:00 pm. Office hours: Monday 12:50 1:20 (ECCH 134) Lectures 6 8 Outline Stem Cell Division - symmetric - asymmetric Stem cell lineage potential - pluripotent
CLINICAL TRANSLATION OF STEM CELL THERAPIES - INTELLECTUAL PROPERTY AND ANTICIPATORY GOVERNANCE
Volume 7, Issue 2, August 2010 CLINICAL TRANSLATION OF STEM CELL THERAPIES - INTELLECTUAL PROPERTY AND ANTICIPATORY GOVERNANCE Abstract Yann Joly * Though promoted as the next pillar of medical care, stem
GROW YOUR BUSINESS AND MAINTAIN A COMPETITIVE EDGE: THE CHANGING NATURE OF THE AUCTION INDUSTRY
GROW YOUR BUSINESS AND MAINTAIN A COMPETITIVE EDGE: THE CHANGING NATURE OF THE AUCTION INDUSTRY EXECUTIVE SUMMARY The business of buying and selling inventory is challenging. Asset owners are constantly
8 th Regenerative Medicine and Stem Cells
8 th Regenerative Medicine and Stem Cells Theme: Light the Hope of Incurable Diseases March 19 21, 2 15 Busan, Republic of Korea Welcome Message Dear Friends and Colleagues, On behalf of the Organizing
COLR Technology. Color Customization on Demand Solution Ready, Technology Innovation Dr. Srinivas Rao
Color Customization on Demand Solution Ready, Technology Innovation Dr. Srinivas Rao Color Customization on Demand Solution Ready, Technology Innovation Abstract: In nature color is rampant, vivid and
UNIT OUTLINE. Biotechnology 331. Unit Code Unit Coordinator: Dr Keith Gregg. Semester School of Biomedical Sciences
Unit Code 307698 Biotechnology 331 Unit Coordinator: Dr Keith Gregg School of Biomedical Sciences UNIT OUTLINE Semester 1 2012 CRICOS (Perth - 00301J) (Sydney - 02637B) Table of Contents INTRODUCTION...
Determinants of the pace of global innovation in energy technologies
Determinants of the pace of global innovation in energy technologies Luís M. A. Bettencourt *, Jessika E. Trancik *+, Jasleen Kaur * Contributed equally + Correspondence to: trancik@mit.edu Supporting
Option to License Deals: Finding a Winning Balance October 15, 2012
LES 2012 Meetings Option to License Deals: Finding a Winning Balance October 15, 2012 1 Panelists Hemmie Chang, Esq. Chair, Licensing & Strategic Alliances Group, Partner, Life Sciences Group George Adams
Annual Report
2008 2009 Annual Report C O D E C O M P L I A N C E R E V I E W B O A R D B E E R I N S T I T U T E C C R B 2 0 0 9 A N N U A L R E P O R T 1 BOARD MEMBERS William H. Cunningham Chairman Rory Davies Paul
Medical Practitioner. Medical Practitioner. Medical Practitioner. Medical Practitioner. Medical Practitioner. Medical Practitioner
Local GP - Trusted Doctor providing stem cell therapy for patients willing to pay even though the treatment is yet to be proven. Local specialist performing a case study with patients funding their own
3/16/2018 Data-Dynamix Proprietary Information 1
Exclusive Partner 3/16/2018 Data-Dynamix Proprietary Information 1 The Tests Of Time What were you doing 20-years ago? Becoming a Father 3/16/2018 Data-Dynamix Proprietary Information 2 The Tests Of Time
Agilent Seahorse XF Live-Cell Metabolism Solutions for STEM CELL RESEARCH
Agilent Seahorse XF Live-Cell Metabolism Solutions for STEM CELL RESEARCH MONITOR CELL FATE TRANSITIONS Improve Differentiation and Reprogramming Outcomes Adult Fibroblast Cells Reprogramming (ips Cells)
Stem Cell and Regenerative Medicine 50+ B2B Meetings. conferenceseries.com. 10 th Annual Conference on. August 13-14, 2018 London, UK
10 th Annual Conference on conferenceseries.com Stem Cell and Regenerative Medicine August 13-14, 2018 London, UK Dear Attendees, Invitation We are glad to announce the 10 th Annual Conference on Stem
UCI ADMINISTRATIVE POLICIES & PROCEDURES
UCI ADMINISTRATIVE POLICIES & PROCEDURES RESEARCH AND SPONSORED ACTIVITIES Human Stem Cell Research Oversight Program Section 484-1: Review of Human Stem Cell Activities Responsible Office: Office of Research
E. Rehbinder M. Engelhard K. Hagen R. B. Jorgensen R. Pardo-Avellaneda A. Schnieke F. Thiele
E. Rehbinder M. Engelhard K. Hagen R. B. Jorgensen R. Pardo-Avellaneda A. Schnieke F. Thiele Pharming Promises and risks of biopharmaceuticals derived from genetically modified plants and animals 4ü Springer
Research Indicators in Green Chemistry
0 Research Indicators in Green Chemistry Guilherme Sepe Research Intelligence Oct-09-2017 Data Sources 1 2 Research: Scopus World s Largest Abstract & Citation database with 69M+ records from 5,000+ publishers
Crisis Management. November 10, 2016
Crisis Management November 10, 2016 2 Panelists Patricia Diaz Dennis Board Member, U.S. Steel and Entravision Chris Hodges CEO and Founder, Alpha IR Group Jim Snyder President, Global Mobile, LLC Rebecca
Stem Cel s Key Words:
Stem Cells Key Words: Embryonic stem cells, Adult stem cells, ips cells, self-renewal, differentiation, pluripotent, multipotent, Inner cell mass, Nuclear transfer (Therapeutic cloning), Feeder cells,
COMPETE COMPetition Electronic Training Experience Beyond Competition Compliance
COMPETE COMPetition Electronic Training Experience Beyond Competition Compliance May 2011 Antitrust, Competition and Economic Regulation What s COMPETE? A CUSTOMISABLE competition law compliance e-learning,
How to Organize and Run a Small Business
How to Organize and Run a Small Business How to Organize and Run a Small Business Copyright 2014 by DELTACPE LLC All rights reserved. No part of this course may be reproduced in any form or by any means,
MATERIAL TRANSFER AGREEMENT
MATERIAL TRANSFER AGREEMENT I. Parties: 1. PROVIDER: (ASC), a California corporation with an address of Milpitas, CA. 2. RECIPIENT: 3. RECIPIENT SCIENTIST(s): II. Definitions: 1. COMMERCIAL PURPOSES: The
#ASKDOUG. * Other names and brands may be claimed as the property of others.
#ASKDOUG MOBILE THE INTERNET OFTHINGS IS HOME NETWORK INFRASTRUCTURE DATA CENTER / CLOUD INDUSTRIAL We are Here! The Hype curve 50B DEVICES INTERNET THE OFTHINGS IS 35 ZETABYTES DEVICES NETWORK INFRASTRUCTURE
Supplementary Notes for Not Quite a Myriad of Gene Patents
Not Quite a Myriad of Gene Patents Authors: Gregory D. Graff 1,,*, Devon Phillips 2, Zhen Lei 3,, Sooyoung Oh 4, Carol Nottenburg 5,, Philip G. Pardey 2, Affiliations 1 Department of Agricultural and Resource
COUNCIL OF THE EUROPEAN UNION. Brussels, 19 July 2005 (20.07) (OR. fr) 11341/05 PI 18
COUNCIL OF THE EUROPEAN UNION Brussels, 19 July 2005 (20.07) (OR. fr) 11341/05 PI 18 COVER NOTE from: Secretary-General of the European Commission, signed by Ms Patricia BUGNOT, Director date of receipt:
HUMAN CLONING PROHIBITION ACT
HUMAN CLONING PROHIBITION ACT Model Legislation & Policy Guide For the 2017 Legislative Year Accumulating Victories, Building Momentum, Advancing a Culture of Life in America INTRODUCTION With each passing
HUMAN CLONING PROHIBITION ACT. Model Legislation & Policy Guide For the 2014 Legislative Year
HUMAN CLONING PROHIBITION ACT Model Legislation & Policy Guide For the 2014 Legislative Year INTRODUCTION With each passing year, we face new and increasingly complex challenges to the sanctity of human
THE GLOBAL MARKET FOR STEM CELLS
THE GLOBAL MARKET FOR STEM CELLS BIO035F May 2016 Paul Evers Project Analyst ISBN: 1-62296-292-3 BCC Research 49 Walnut Park, Building 2 Wellesley, MA 02481 USA 866-285-7215 (toll-free within the USA),
HUMAN CLONING PROHIBITION ACT
HUMAN CLONING PROHIBITION ACT Model Legislation & Policy Guide For the 2016 Legislative Year Accumulating Victories, Building Momentum, Advancing a Culture of Life in America INTRODUCTION With each passing
I/P Engine, Inc. v. AOL, Inc. et al Doc. 438 Att. 11 EXHIBIT K. Dockets.Justia.com
I/P Engine, Inc. v. AOL, Inc. et al Doc. 438 Att. 11 EXHIBIT K Dockets.Justia.com IN THE UNITED STATES DISTRICT COURT FOR THE EASTERN DISTRICT OF VIRGINIA I/P ENGINE, INC., Plaintiff, v. AOL, INC., GOOGLE
Genetic Technologies
Genetic Technologies Distinguish the terms biotechnology, recombinant DNA technology, transgenic organisms, genetic engineering Understand the two basic techniques to obtain selective fragments of DNA
The Wildfire Menace: Will the West Learn or Burn? How to Learn From History Instead of Repeating it. webcast option
Presented by the Sandra Day O Connor College of Law and co-sponsored by the Salt River Project (SRP), Dickinson Wright, PLLC, and Northern Arizona University Ecological Restoration Institute webcast option
BioWhittaker specialty media Maximize your cell growth and productivity
BioResearch BioWhittaker specialty media Maximize your cell growth and productivity BioWhittaker specialty media cell culture applications BioResearch BioWhittaker specialty media Maximize your cell growth
Directed differentiation of human embryonic stem cells
Directed differentiation of human embryonic stem cells TECAN Symposium 2008 Biologics - From Benchtop to Production Wednesday 17 September 2008 Andrew Elefanty Embryonic Stem Cell Differentiation Laboratory,
Transitioning from Manual Meter Reading/CMR to a Successful AMR Deployment. Ralph Kennedy, Vice President Utility Meter Services, Inc.
Transitioning from Manual Meter Reading/CMR to a Successful AMR Deployment Ralph Kennedy, Vice President Utility Meter Services, Inc. Company Overview Asplundh Tree Expert Co. Parent (>28,000 Employees)